By Editor , 10 September 2026
Wooree Group Pushes 'Six Pillars' Standard for Liposome Health Products

Bangkok -- September 7, 2026 -- Wooree Group, a South Korean biotechnology and lighting conglomerate with 60 years of history, has called for a scientific validation standard for the liposomal health products market, following its participation in Vitafoods Asia 2026 held September 2-4 in Bangkok.

By Editor , 10 September 2026

Seoul – September 09, 2026 -- The Ministry of Food and Drug Safety of Korea (MFDS) concluded the 12th Global Bio Conference (GBC) on August 28, drawing roughly 5,600 participants from 19 countries to the Grand InterContinental Seoul Parnas for three days of talks on biopharmaceutical regulation and technology.

By Editor , 10 September 2026
Aluminum Refractory Materials Market to Hit $2.73B by 2031

Delray Beach, Fla. – September 09, 2026 -- The global aluminum refractory materials market is projected to grow from USD 2.17 billion in 2026 to USD 2.73 billion by 2031, expanding at a compound annual growth rate of 4.77%, according to MarketsandMarkets.

By Editor , 10 September 2026
Rznomics Boosts Circular RNA Yield 7-Fold, Beats PIE Method 2x

Seongnam, South Korea – September 09, 2026 -- Rznomics Inc. (KOSDAQ: 476830) has achieved up to a seven-fold increase in circular RNA (circRNA) production efficiency through engineering upgrades to its proprietary Self-Targeting and Splicing (STS) platform, according to peer-reviewed research published in Nucleic Acids Research on September 4, 2026.

By Editor , 10 September 2026

Shanghai – September 09, 2026 -- Clover Biopharmaceuticals (HKEX: 02197) reported positive preliminary Phase 2 data in Australia for two combination respiratory vaccine candidates, SCB-1022 (RSV+hMPV) and SCB-1033 (RSV+hMPV+PIV3), targeting older adults aged 60-85.

Trial enrolled 420 older adults across multiple Australian sites

The randomized, observer-blinded study randomized 420 participants to receive SCB-1022, SCB-1033 or placebo. Antibody titers at 28 days post-vaccination were in line with or trended higher than prior Phase 1 results.

By Editor , 10 September 2026

Hong Kong – September 09, 2026 -- Ping An Insurance (Group) Company of China (HKEX: 2318; SSE: 601318) has been upgraded to an A+ rating in the 2026 Hang Seng Sustainability Rating, marking its third consecutive annual improvement and placing the insurer among the top 10% of financial companies assessed.

By Editor , 10 September 2026

Hong Kong – September 09, 2026 -- A coalition of seven institutions including HSBC, the Asian Infrastructure Investment Bank (AIIB) and Temasek-backed GenZero has launched the Green Accelerator (GA), a non-profit platform designed to convert green technology projects in emerging markets into investment-ready assets for multilateral development banks, sovereign wealth funds and commercial lenders.

By Editor , 10 September 2026

Hong Kong – September 09, 2026 -- Fosun International Limited (HKEX: 00656) has had its Hang Seng Sustainability Rating upgraded from AA- to AA+, a record high for the Group, following the 2026 ratings review by Hang Seng Indexes Company Limited that took effect the same day.

By Editor , 10 September 2026

Hong Kong – September 09, 2026 -- Ping An Insurance (Group) Company of China, Ltd. (HKEX: 2318; SSE: 601318) has been upgraded from A to A+ in the 2026 Hang Seng Sustainability Rating, marking the third consecutive annual improvement for the insurer. The upgrade places Ping An's A-shares in the top 10% of both the broader A-share universe and financial-sector peers, while its H-shares rank in the top 20% of Hong Kong-listed companies and top 10% of financials.